Literature DB >> 30722839

Mechanical Ventilation and Extracorporeal Membrane Oxygena tion in Acute Respiratory Insufficiency.

Falk Fichtner1, Onnen Moerer2, Sven Laudi1, Steffen Weber-Carstens3, Monika Nothacker4, Udo Kaisers5.   

Abstract

BACKGROUND: Mechanical ventilation is life-saving for patients with acute respiratory insufficiency. In a German prevalence study, 13.6% of patients in intensive care units received mechanical ventilation for more than 12 hours; 20% of these patients received mechanical ventilation as treatment for acute respiratory distress syndrome (ARDS). The new S3 guideline is the first to contain recommendations for the entire process of treatment in these groups of patients (indications, ventilation modes/parameters, ac- companying measures, treatments for refractory impairment of gas exchange, weaning, and follow-up care).
METHODS: This guideline was developed according to the GRADE methods. Pertinent publications were identified by a systematic search of the literature, the quality of the evidence was evaluated, a risk/benefit assessment was conducted, and recommendations were issued by interdisciplinary consensus.
RESULTS: Mechanical ventilation is recommended as primary treatment for patients with severe ARDS. In other patient groups, non-in- vasive ventilation can lower mortality. If mechanical ventilation is needed, ventilation modes allowing spontaneous breathing seem beneficial (quality of evidence [QoE]: very low). Protective ventilation (high positive end-expiratory pressure, low tidal volume, limited peak pressure) improve the survival of ARDS patients (QoE: high). If a severe impairment of gas exchange is present, prone posi- tioning lessens mortality (QoE: high). Veno-venous extracorporeal membrane oxygenation (vvECMO) has not unequivocally been shown to improve survival. Early mobilization and weaning protocols can shorten the duration of ventilation (QoE: moderate).
CONCLUSION: Recommendations for patients undergoing mechanical ventilation include lung-protective ventilation, early sponta- neous breathing and mobilization, weaning protocols, and, for those with severe impairment of gas exchange, prone positioning. It is further recommended that patients with ARDS and refractory impairment of gas exchange should be transferred to an ARDS/ECMO center, where extracorporeal methods should be applied only after application of all other therapeutic options.

Entities:  

Mesh:

Year:  2018        PMID: 30722839      PMCID: PMC6375070          DOI: 10.3238/arztebl.2018.0840

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  37 in total

1.  [Integrative assessment of evidence in healthcare: the GRADE system].

Authors:  Holger Schünemann
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2009

2.  [GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables].

Authors:  Gero Langer; Joerg J Meerpohl; Matthias Perleth; Gerald Gartlehner; Angela Kaminski-Hartenthaler; Holger Schünemann
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2012-06-06

3.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

4.  Neuromuscular blockers in early acute respiratory distress syndrome.

Authors:  Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

Review 5.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis.

Authors:  Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

Review 6.  Lung protective ventilation strategy for the acute respiratory distress syndrome.

Authors:  Nicola Petrucci; Carlo De Feo
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  High-frequency oscillation in early acute respiratory distress syndrome.

Authors:  Niall D Ferguson; Deborah J Cook; Gordon H Guyatt; Sangeeta Mehta; Lori Hand; Peggy Austin; Qi Zhou; Andrea Matte; Stephen D Walter; Francois Lamontagne; John T Granton; Yaseen M Arabi; Alejandro C Arroliga; Thomas E Stewart; Arthur S Slutsky; Maureen O Meade
Journal:  N Engl J Med       Date:  2013-01-22       Impact factor: 91.245

8.  Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury.

Authors:  Christian Putensen; Nils Theuerkauf; Jörg Zinserling; Hermann Wrigge; Paolo Pelosi
Journal:  Ann Intern Med       Date:  2009-10-20       Impact factor: 25.391

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Early intensive care sedation predicts long-term mortality in ventilated critically ill patients.

Authors:  Yahya Shehabi; Rinaldo Bellomo; Michael C Reade; Michael Bailey; Frances Bass; Belinda Howe; Colin McArthur; Ian M Seppelt; Steve Webb; Leonie Weisbrodt
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

View more
  19 in total

Review 1.  [Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges].

Authors:  C Karagiannidis; T Bein; S Weber-Carstens
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-02-05       Impact factor: 0.840

2.  In Reply.

Authors:  Falk Fichtner; Sven Laudi
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

3.  Conflicting Results.

Authors:  Michael Schütz; Hans-Bernd Hopf
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

Review 4.  Invasive and Non-Invasive Ventilation in Patients With COVID-19.

Authors:  Wolfram Windisch; Steffen Weber-Carstens; Stefan Kluge; Rolf Rossaint; Tobias Welte; Christian Karagiannidis
Journal:  Dtsch Arztebl Int       Date:  2020-08-03       Impact factor: 5.594

Review 5.  Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.

Authors:  Friedrich Hohmann; Lisa Wedekind; Felicitas Grundeis; Steffen Dickel; Johannes Frank; Martin Golinski; Mirko Griesel; Clemens Grimm; Cindy Herchenhahn; Andre Kramer; Maria-Inti Metzendorf; Onnen Moerer; Nancy Olbrich; Volker Thieme; Astrid Vieler; Falk Fichtner; Jacob Burns; Sven Laudi
Journal:  Cochrane Database Syst Rev       Date:  2022-06-29

Review 6.  Evidence-Based Considerations for the Design of an Open-Source Ventilator: A Systematic Review.

Authors:  Chintan Dave; Asaanth Sivajohan; John Basmaji; Marat Slessarev
Journal:  Crit Care Explor       Date:  2022-06-30

Review 7.  [What is evidence-based in the treatment of sepsis?]

Authors:  K Stahl; B Seeliger; S David; J Schmidt
Journal:  Internist (Berl)       Date:  2020-12       Impact factor: 0.743

8.  [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].

Authors:  M Pfeifer; S Ewig; T Voshaar; W Randerath; T Bauer; J Geiseler; D Dellweg; M Westhoff; W Windisch; B Schönhofer; S Kluge; P M Lepper
Journal:  Pneumologie       Date:  2020-04-22

Review 9.  [Treatment of severe COVID-19 courses in intensive care medicine].

Authors:  O Wiesner; M Busch; S David
Journal:  Internist (Berl)       Date:  2020-08       Impact factor: 0.743

Review 10.  [COVID-19 pneumonia].

Authors:  M Pfeifer; O W Hamer
Journal:  Internist (Berl)       Date:  2020-08       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.